GENHEALTH, INC.
StreetZero Signal 79
About GENHEALTH, INC.
GenHealth AI is a biotechnology company developing generative AI tools for healthcare administration and clinical applications. It offers AI agents that perform patient intake, eligibility verification, prior authorization, billing, and claims management within existing EHR and payer systems. The company, a 1upHealth spinoff, focuses on large medical models (LMMs) trained on healthcare standards like FHIR to uncover clinical relationships and automate workflows without human prompting.
LATEST FUNDINGPrivate Placement
$16.5M
Announced 2026-09-29
TOTAL RAISED$29.5M
IN THE NEWS
EMPLOYEES—
FOUNDED—
HQVienna, VA, USA
Industry
Biotechnology
Tags
AIHealthcareBiotechnologySeries A
Investors
Key highlights
- Raised $16.5M Series A in September 2026 for a total of $29.5M.
- Spun out of 1upHealth and closed $13M seed round in 2023.
- Developing large medical models to automate prior authorization, billing, and claims.
- Backed by 22 investors including Craft Ventures and Flare Capital Partners.
- AI agents integrate with EHRs and payer systems using FHIR and HL7 standards.
Ask StreetZero about GENHEALTH, INC.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account